← All companies
Novartis AG
NVS
Market cap$283.13 B
Rank#47
SEC filings947
The table below shows Novartis AG's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | $11.51B | $9.70B | $8.40B | $9.33B | $9.38B | $8.19B |
| R&D | $2.73B | $2.37B | $2.30B | $2.50B | $2.40B | $2.44B |
| SG&A |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.